Trial intelligence / Profile preview

Effect of Estrogen on the Stress Response for Postmenopausal Women

NCT00220454Phase 2Completed

Sponsor
Seattle Institute for Biomedical and Clinical Research
Start
Dec 2002
Modality
Small Molecules
01

Overview

Phase 2, randomised, double-blind trial of estradiol and hydrocortisone in menopause (4 arms), sponsored by Seattle Institute for Biomedical and Clinical Research. Primary endpoint: Change in cognitive test scores at 3 months. Started Dec 2002; status: completed.

02

Drugs

estradiolhydrocortisone
03

Conditions

menopause

Beyond the preview

Go deeper on NCT00220454.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00220454.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call